SCHEMBL119853

SCHEMBL119853

O=Cc1cc(C(O)CNCCc2ccc(NCC(O)c3ccccc3)cc2)ccc1O

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 19/20 0.74
ADRB1 P08588 4/20 0.74
ADRB3 P13945 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL28027090 0.96 ADRB2 (0.70) ADRB2ADRB1ADRB3
Milveterol SCHEMBL1920578 0.92 ADRB2 (0.89) ADRB2ADRB1ADRB3
Milveterol SCHEMBL29448200 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL168972 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL265694 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL265695 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL4385046 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL185356 0.85 ADRB2 (1.00) ADRB2ADRB1ADRB3
Milveterol SCHEMBL2014102 0.85 ADRB2 (0.98) ADRB2ADRB1ADRB3
Milveterol SCHEMBL2014100 0.85 ADRB2 (0.98) ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 194 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152341-B2 ATOMIZER IN THE FORM OF AN INHALER FOR MEDICAL AEROSOL THERAPY BOEHRINGER INGELHEIM PHARMA (DE) 2025-04-02 EP disclosed
US-11369760-B2 Inhalation atomizer comprising a blocking function and a counter ANOVENT PHARMACEUTICAL (U.S.), LLC (US) 2022-06-28 US disclosed
EP-3508239-B1 ADAPTER, INHALANT APPARATUS AND ATOMIZER BOEHRINGER INGELHEIM INT (DE) 2020-12-23 EP disclosed
EP-2326374-B1 INHALER BOEHRINGER INGELHEIM INT (DE) 2020-03-04 EP disclosed
EP-2066380-B1 INHALER BOEHRINGER INGELHEIM INT (DE) 2019-10-09 EP disclosed
EP-3508239-A1 ADAPTER, INHALANT APPARATUS AND ATOMIZER Boehringer Ingelheim International GmbH (DE) 2019-07-10 EP disclosed
EP-2656867-B1 Mouthpiece for an inhalator BOEHRINGER INGELHEIM PHARMA (DE) 2019-05-15 EP disclosed
US-20190030268-A1 Inhalation Atomizer Comprising a Blocking Function and a Counter ANOVENT PHARMACEUTICAL (U.S.), LLC 2019-01-31 US disclosed
US-20180344956-A1 Inhaler Device for Administering Powered Pharmaceutical Compositions via Inhalation HUANG CAI GU (US) 2018-12-06 US disclosed
EP-2007456-B1 MOUTHPIECE FOR AN INHALER BOEHRINGER INGELHEIM PHARMA (DE) 2018-10-17 EP disclosed
US-20070240713-A1 INHALER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-18 US disclosed
WO-2007116002-A1 INHALER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-18 WO disclosed
WO-2007110402-A1 PACKAGING MEANS FOR MULTI-DOSE POWDER INHALERS WITH OPTIMIZED DISCHARGING PROPERTIES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-04 WO disclosed
WO-2007062721-A1 DISPENSING DEVICE, STORAGE DEVICE AND METHOD FOR DISPENSING A FORMULATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-07 WO disclosed
WO-2007062726-A2 DISPENSING DEVICE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-06-07 WO disclosed
WO-2007057362-A1 NEEDLE FOR PUNCTURING POWDER CAPSULES FOR INHALATION BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2007-05-24 WO disclosed
WO-2007051536-A1 METHOD AND DEVICE FOR METERING MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG (DE) 2007-05-10 WO disclosed
WO-2007048763-A1 INHALER WITH MOUTHPIECE HAVING A MICROBIOLOGICAL PROTECTIVE FUNCTION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-05-03 WO disclosed
WO-2007045670-A1 OPTICAL SEMI-QUANTITATIVE 100 % FILLING CHECK OF PHARMACEUTICAL CAPSULES ON CAPSULE FILLING MACHINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-04-26 WO disclosed
WO-2007023167-A1 TRANSCORNEAL SYSTEM FOR DELIVERY OF A PHARMACEUTICAL AGENT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190030268-A1 Inhalation Atomizer Comprising a Blocking Function and a Counter INF2, ADRA2B, ADRB2 ADRB2 3/4885ADRB1 7/4885ADRB3 30/4885
US-20180344956-A1 Inhaler Device for Administering Powered Pharmaceutical Compositions via Inhalation CAPRIN1, SPOP, CAPZB ADRB2 812/4885ADRB1 1487/4885ADRB3 2266/4885
US-11369760-B2 Inhalation atomizer comprising a blocking function and a counter ADRB2, ADRB1, ADRA2B ADRB2 1/4885ADRB1 2/4885ADRB3 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.